Elena Pfeuffer-Jovic

Mar 1, 2023 | resmedjournal.com | Matthias Held |Elena Pfeuffer-Jovic |Heinrike Wilkens |Homburg Saar

The influence of the new pulmonary hypertension (PH) definition on the incidence of chronic thromboembolic PH (CTEPH) is unclear. The incidence of chronic thromboembolic pulmonary disease without PH (CTEPD) is unknown. To determine the frequency of CTEPH and CTEPD using the new mPAP cut-off >20 mmHg for PH in patients who have suffered an incidence of pulmonary embolism (PE) and were recruited into an aftercare program.